Novonesis A/S : Resolutions from the annual shareholders' meeting 2024
April 30, 2024 at 12:16 pm EDT
Share
English
Published: 2024-04-30 18:02:02 CEST
Novonesis (Novozymes) A/S
Decisions of general meeting
Resolutions from the annual shareholders' meeting 2024
Today an ordinary shareholders' meeting was conducted. The following resolutions were made:
• Approval of the audited Annual Report for 2023
• Approval of distribution of profit with payment of an ordinary dividend of DKK 2.00 or EUR 0.27 per A/B share of DKK 2 for the last four months (September 1 - December 31) of 2023. Legacy Novozymes shareholders will then have received a total pay-out of the 2023 adjusted net profit of DKK 6.20 per share, which equals an increase of 3% compared with 2022.
• Approval of the Remuneration Report for 2023
• Approval of the remuneration of members of the Board of Directors
• Re-election of Cornelis (Cees) de Jong as Chair and Jesper Brandgaard as Vice Chair of the Board of Directors
• Re-election of Heine Dalsgaard, Sharon James, Kasim Kutay, Lise Kaae, Kevin Lane, Morten Sommer and Kim Stratton as members of the Board of Directors
• Election of EY Godkendt Revisionspartnerselskab as the company's auditors in respect of statutory financial and sustainability reporting
• Approval to renew authorizations to the Board of Directors to implement capital increases
• Approval to renew the authorization to the Board of Directors to acquire treasury shares
• Approval of authorization to the Board of Directors to distribute extraordinary dividends
• Approval of amendments to the Articles of Association
• Approval of amendments to the Remuneration Policy
Following the annual shareholders' meeting, the Board of Directors consists of the following members:
• Cornelis (Cees) de Jong, Chair
• Jesper Brandgaard, Vice Chair
• Heine Dalsgaard
• Sharon James
• Kasim Kutay
• Lise Kaae
• Kevin Lane
• Morten Sommer
• Kim Stratton
Employee representatives:
• Anne Breum
• Anders Hentze Knudsen
• Preben Nielsen
• Jens Øbro
• Karen Louise Lauesen, observer
• Kim Ib Sørensen, observer
For further information on members of the Board of Directors, please go to www.novonesis.com
Attachment
2024_14_AGM_Resolutions
Attachments:
2024_14_AGM_Resolutions.pdf
This news release was distributed by Company News System, www.nasdaqomxnordic.com/news/marketnotices
To subscribe on regulatory news from this company, go to the subscription page
Attachments
Original Link
Permalink
Disclaimer
Novonesis A/S published this content on
30 April 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
30 April 2024 16:15:12 UTC.
Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows:
- industry of cleaning and household maintenance products (28.5%);
- bioenergy (24.8%);
- food industry and human health (22.1%);
- technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries;
- agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods.
Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).
NOVONESIS A/S 
